Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Tips for Handling Less Common Rheumatoid Arthritis-Related Disorders

Thomas R. Collins  |  Issue: February 2017  |  February 16, 2017

ldutko/shutterstock.com

ldutko/shutterstock.com

WASHINGTON, D.C.—As treatments for rheumatoid arthritis (RA) improve, some related conditions that used to be common in patients with RA are not seen very often anymore, but they still exist and physicians need to know how to identify them.

Speaking to attendees at the ACR/ARHP Annual Meeting talk titled Rheumatoid Arthritis—A Case-Based Approach to Selected Extra-Articular Challenges and What You Are Missing with Better Therapies, part of the ACR Review Course, expert Jonathan Coblyn, MD, director of clinical rheumatology at Brigham and Women’s Hospital in Boston, outlined several clinical cases to support his main message. He reviewed cases involving several conditions that newer treatments have made fairly rare: central nervous system (CNS) manifestations of RA, cervical spine involvement, Felty’s syndrome and large granular lymphocyte (LGL) leukemia.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

CNS Manifestations in RA

This case involved a 71-year-old man with a long history of RA and pulmonary fibrosis who has been on azathioprine and received a yearly rituximab injection. Two months before being admitted, he’d developed persistent hiccups. A chest X-ray led to treatment of community-acquired pneumonia, after which he did better. But the symptoms returned, and he came back two weeks later with the hiccups again, had lost 30 lbs. and couldn’t swallow liquids or solids.

CNS manifestations of RA include CNS vasculitis; rheumatoid nodules; sterile meningitis and pachymeningitis; infections, including progressive multifocal leukoencephalopathy (PML); hyperviscosity syndromes; cerebrovascular disease; CNS tumors or lymphoma; and effects of medication.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

PML has to be a consideration when a patient is on rituximab, but involves neuroimaging that is distinct, meaning that it is limited to the white matter and doesn’t conform to vascular areas as vasculitis would, Dr. Coblyn said. The man was transferred to Brigham and Women’s Hospital.

“He had hiccups that were persistent; that was our clue,” Dr. Coblyn said. A neurologist said that whenever hiccups are involved, attention should be paid to the area postrema, a region in the dorsal surface of the medulla oblongata that lacks the blood–brain barrier and can detect emetic toxins in the brain and the blood. By examining the findings of his magnetic resonance imaging test, they determined that the man had significant inflammation in the area postrema. More studies were done, including flow cytometry of the cerebrospinal fluid, and the man was given broad-spectrum antibiotics and antifungals.

But—as often happens in these cases, Dr. Coblyn said—the diagnosis was made at autopsy. Neuropathology eventually found he had diffuse large B-cell lymphoma, with “notable involvement of basilar leptomeninges by [Epstein-Barr] EBV-virus lymphoma.”

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsRheumatoid Arthritis Tagged with:2016 ACR/ARHP Annual MeetingClinicalFelty's syndromelarge granular lymphocyte leukemiaManagementpatient careRheumatic DiseaseRheumatoid arthritisrheumatologistrheumatologyTreatmentVasculitis

Related Articles

    Case Report: Rheumatoid Arthritis Complicated by Large Granular Lymphocytic Leukemia

    November 14, 2021

    Large granular lymphocytic (LGL) leukemia is a rare, chronic, lymphoproliferative disorder of cytotoxic T cell or natural killer cell lineage with an annual incidence of 0.72 cases per 1 million people in the U.S.1 The most common sub­type of LGL leukemia, T-LGL leukemia, follows an indolent disease course and accounts for approximately 85% of cases….

    Rheumatologist Dr. Jonathan Coblyn Releases Stress by Fishing

    July 12, 2016

    Jonathan Coblyn, MD, was around 10 years old the first time his father took him fishing in April to Great South Bay, the largest shallow saltwater bay in New York. It was so cold that he remembers scraping frost off the lines that tied the family’s 26-foot motorboat to the pier. Dr. Coblyn, clinical chief…

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    The Demise of the Inpatient Rheumatology Unit

    July 19, 2018

    Through much of the 20th century, dedicated rheumatic disease units were found in hospitals across the U.S. and countries around the world. In the latter part of the century, this began to change, with hospitals moving toward the consult model of care for rheumatic patients. This change reflects larger shifts in the medical world toward…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences